08.09.20
28.08.20
GAINESVILLE, FL – (BusinessWire) – August 27, 2020 – Cyclo Therapeutics, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C (NPC) and Alzheimer’s Disease, today announced that it has closed a private placement of its securities with a group of accredited investors...
Read more21.08.20
We are excited to announce that registration for our very first Digital Annual Family Conference & Interactive Workshop on Niemann-Pick Disease, is now open!
Read more20.07.20
09.07.20